Holly J - Search Results

1

C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire.

Kosik I, Da Silva Santos J, Angel M, Hu Z, Holly J, Gibbs JS, Gill T, Kosikova M, Li T, Bakhache W, Dolan PT, Xie H, Andrews SF, Gillespie RA, Kanekiyo M, McDermott AB, Pierson TC, Yewdell JW. Kosik I, et al. Among authors: holly j. Sci Immunol. 2024 Mar 22;9(93):eadj9534. doi: 10.1126/sciimmunol.adj9534. Epub 2024 Mar 22. Sci Immunol. 2024. PMID: 38517951

2

Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity.

López-Muñoz AD, Kosik I, Holly J, Yewdell JW. López-Muñoz AD, et al. Among authors: holly j. Sci Adv. 2022 Aug 5;8(31):eabp9770. doi: 10.1126/sciadv.abp9770. Epub 2022 Aug 3. Sci Adv. 2022. PMID: 35921414 Free PMC article.

3

DRiPs get molecular.

Yewdell JW, Hollý J. Yewdell JW, et al. Among authors: holly j. Curr Opin Immunol. 2020 Jun;64:130-136. doi: 10.1016/j.coi.2020.05.009. Epub 2020 Jun 29. Curr Opin Immunol. 2020. PMID: 32615334 Review.

4

A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion.

Dersh D, Hollý J, Yewdell JW. Dersh D, et al. Among authors: holly j. Nat Rev Immunol. 2021 Feb;21(2):116-128. doi: 10.1038/s41577-020-0390-6. Epub 2020 Aug 20. Nat Rev Immunol. 2021. PMID: 32820267 Review.

5

Author Correction: A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion.

Dersh D, Hollý J, Yewdell JW. Dersh D, et al. Among authors: holly j. Nat Rev Immunol. 2020 Oct;20(10):644. doi: 10.1038/s41577-020-00445-3. Nat Rev Immunol. 2020. PMID: 32873889

6

Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity.

López-Muñoz AD, Kosik I, Holly J, Yewdell JW. López-Muñoz AD, et al. Among authors: holly j. Res Sq [Preprint]. 2021 Dec 13:rs.3.rs-1162804. doi: 10.21203/rs.3.rs-1162804/v1. Res Sq. 2021. PMID: 34931184 Free PMC article. Updated. Preprint.

7

Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity.

López-Muñoz AD, Kosik I, Holly J, Yewdell JW. López-Muñoz AD, et al. Among authors: holly j. bioRxiv [Preprint]. 2021 Dec 13:2021.12.10.472169. doi: 10.1101/2021.12.10.472169. bioRxiv. 2021. PMID: 34931195 Free PMC article. Updated. Preprint.

8

Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond.

Kwon HJ, Kosikova M, Tang W, Ortega-Rodriguez U, Radvak P, Xiang R, Mercer KE, Muskhelishvili L, Davis K, Ward JM, Kosik I, Holly J, Kang I, Yewdell JW, Plant EP, Chen WH, Shriver MC, Barnes RS, Pasetti MF, Zhou B, Wentworth DE, Xie H. Kwon HJ, et al. Among authors: holly j. iScience. 2022 Dec 22;25(12):105507. doi: 10.1016/j.isci.2022.105507. Epub 2022 Nov 5. iScience. 2022. PMID: 36373096 Free PMC article.

9

Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs.

Kazemi S, López-Muñoz AD, Hollý J, Jin L, Yewdell JW, Dolan BP. Kazemi S, et al. Among authors: holly j. bioRxiv [Preprint]. 2021 Oct 22:2021.10.21.465386. doi: 10.1101/2021.10.21.465386. bioRxiv. 2021. PMID: 34729559 Free PMC article. Updated. Preprint.

10

Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.

Kazemi S, López-Muñoz AD, Hollý J, Jin L, Yewdell JW, Dolan BP. Kazemi S, et al. Among authors: holly j. J Virol. 2022 Sep 14;96(17):e0025622. doi: 10.1128/jvi.00256-22. Epub 2022 Aug 24. J Virol. 2022. PMID: 36000847 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page